Literature DB >> 12970887

Mad2 and p53 expression profiles in colorectal cancer and its clinical significance.

Gang-Qiang Li1, Hao Li, Hong-Fu Zhang.   

Abstract

AIM: To investigate the expression of tumor suppressor gene p53 and spindle checkpoint gene Mad2, and to demonstrate their expression difference in colorectal cancer and normal mucosa and to evaluate its clinical significance.
METHODS: Western blot and immunohistochemistry methods were used to analyze the expression of Mad2 in colorectal cancer and its corresponding normal mucosa. The expression of p53 was detected by immunohistochemistry method in colorectal cancer and its corresponding normal mucosa.
RESULTS: Mad2 was significantly overexpressed in colorectal cancer compared with corresponding normal mucosa (P<0.001), and it was not related to the differentiation of adenocarcinoma and other clinical factors (P>0.05). The ratio of Mad2 protein in cancer tissue (C) to that in its normal mucosa tissue (N) was higher than 2, which was more frequently observed in patients with lymph gland metastasis (P<0.05). p53 protein expression was not observed in normal mucosa. The rate of p53 positive expression in adenocarcinomas was 52.6 %. There was a significant difference between adenocarcinomas and normal mucosa(P<0.001), which was not related to the differentiation degree of adenocarcinoma and other clinical factors (P>0.05).
CONCLUSION: Defect of spindle checkpoint gene Mad2 and mutation of p53 gene are involved mainly in colorectal carcinogenesis and C/N>2 is associated with prognosis of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970887      PMCID: PMC4656655          DOI: 10.3748/wjg.v9.i9.1972

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

1.  Specific association of estrogen receptor beta with the cell cycle spindle assembly checkpoint protein, MAD2.

Authors:  G Poelzl; Y Kasai; N Mochizuki; P W Shaul; M Brown; M E Mendelsohn
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Feedback control of mitosis in budding yeast.

Authors:  R Li; A W Murray
Journal:  Cell       Date:  1991-08-09       Impact factor: 41.582

3.  MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells.

Authors:  L S Michel; V Liberal; A Chatterjee; R Kirchwegger; B Pasche; W Gerald; M Dobles; P K Sorger; V V Murty; R Benezra
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

4.  p53 is required for radiation-induced apoptosis in mouse thymocytes.

Authors:  S W Lowe; E M Schmitt; S W Smith; B A Osborne; T Jacks
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

5.  Mutations in the p53 gene occur in diverse human tumour types.

Authors:  J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; N Davidson; S Baylin; P Devilee
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

6.  DNA methylation and genetic instability in colorectal cancer cells.

Authors:  C Lengauer; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

7.  Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.

Authors:  T Miyashita; S Krajewski; M Krajewska; H G Wang; H K Lin; D A Liebermann; B Hoffman; J C Reed
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

8.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

Authors:  S J Kuerbitz; B S Plunkett; W V Walsh; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

9.  Database of p53 gene somatic mutations in human tumors and cell lines.

Authors:  M Hollstein; K Rice; M S Greenblatt; T Soussi; R Fuchs; T Sørlie; E Hovig; B Smith-Sørensen; R Montesano; C C Harris
Journal:  Nucleic Acids Res       Date:  1994-09       Impact factor: 16.971

Review 10.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

View more
  16 in total

1.  Checkpoint-independent stabilization of kinetochore-microtubule attachments by Mad2 in human cells.

Authors:  Lilian Kabeche; Duane A Compton
Journal:  Curr Biol       Date:  2012-03-08       Impact factor: 10.834

Review 2.  Mitotic checkpoint defects: en route to cancer and drug resistance.

Authors:  Sinjini Sarkar; Pranab Kumar Sahoo; Sutapa Mahata; Ranita Pal; Dipanwita Ghosh; Tanuma Mistry; Sushmita Ghosh; Tanmoy Bera; Vilas D Nasare
Journal:  Chromosome Res       Date:  2021-01-06       Impact factor: 5.239

Review 3.  DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatment.

Authors:  S Solier; Y-W Zhang; A Ballestrero; Y Pommier; G Zoppoli
Journal:  Curr Cancer Drug Targets       Date:  2012-05       Impact factor: 3.428

4.  Mad2 overexpression promotes aneuploidy and tumorigenesis in mice.

Authors:  Rocío Sotillo; Eva Hernando; Elena Díaz-Rodríguez; Julie Teruya-Feldstein; Carlos Cordón-Cardo; Scott W Lowe; Robert Benezra
Journal:  Cancer Cell       Date:  2006-12-28       Impact factor: 31.743

Review 5.  Aurea mediocritas: the importance of a balanced genome.

Authors:  Gianluca Varetti; David Pellman; David J Gordon
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-09-18       Impact factor: 10.005

6.  Reduced level of the spindle checkpoint protein BUB1B is associated with aneuploidy in colorectal cancers.

Authors:  E Burum-Auensen; P M DeAngelis; A R Schjølberg; J Røislien; O Mjåland; O P F Clausen
Journal:  Cell Prolif       Date:  2008-08       Impact factor: 6.831

7.  Mitotic arrest deficiency 2 induces carcinogenesis in mucinous ovarian tumors.

Authors:  Yusuke Nakano; Toshiyuki Sumi; Masanari Morishita; Takeshi Fukuda; Hiroyuki Nobeyama; Hiroyuki Yoshida; Yoshinari Matsumoto; Tomoyo Yasui; Osamu Ishiko
Journal:  Oncol Lett       Date:  2011-11-15       Impact factor: 2.967

8.  Expression of mitotic-arrest deficiency 2 predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer.

Authors:  Masanari Morishita; Toshiyuki Sumi; Yusuke Nakano; Masatomo Teramae; Takeshi Fukuda; Hiroyuki Nobeyama; Hiroyuki Yoshida; Yoshinari Matsumoto; Tomoyo Yasui; Osamu Ishiko
Journal:  Exp Ther Med       Date:  2011-12-05       Impact factor: 2.447

9.  Mitotic Origins of Chromosomal Instability in Colorectal Cancer.

Authors:  W Brian Dalton; Vincent W Yang
Journal:  Curr Colorectal Cancer Rep       Date:  2007-04

Review 10.  Losing balance: the origin and impact of aneuploidy in cancer.

Authors:  Andrew J Holland; Don W Cleveland
Journal:  EMBO Rep       Date:  2012-06-01       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.